|Bid||0.00 x 1100|
|Ask||232.00 x 800|
|Day's Range||224.15 - 234.11|
|52 Week Range||76.59 - 331.68|
|Beta (5Y Monthly)||1.62|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In this episode of Influencers, Andy is joined by 23andMe co-founder & CEO, Anne Wojcicki, as they discuss the benefits of DNA testing, concerns over privacy in the healthcare industry, and the future of medicine.
Dr. Cedric Dark, Assistant Professor at Baylor College of Medicine & Board Member with Doctors for America, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Chinese real estate giant China Evergrande Group has warned it might default on debt. First on my list is Novavax (NASDAQ: NVAX). The company might be the next to enter the coronavirus vaccine market.